id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2010-N-0493-0013,FDA,FDA-2010-N-0493,"Agency Information Collection Activities; Proposals, Submissions, and Approvals",Notice,Notice of Approval,2020-12-29T05:00:00Z,2020,12,2020-12-29T05:00:00Z,,2020-12-29T17:10:19Z,2020-28608,0,0,09000064849cfdc6
FDA-2010-N-0493-0012,FDA,FDA-2010-N-0493,Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Additional Criteria and Procedures for Classifying Overthe-Counter Drugs as Generally Recognized as Safe and Effective and Not Misbranded—Time and Extent Applications for Nonprescription Drug Products,Notice,30 Day Proposed Information Collection,2020-10-22T04:00:00Z,2020,10,2020-10-22T04:00:00Z,2020-11-24T04:59:59Z,2020-10-22T12:58:43Z,2020-23357,0,0,0900006484923cea
FDA-2010-N-0493-0011,FDA,FDA-2010-N-0493,Agency Information Collection Activities; Proposed Collection; Comment Request; Additional Criteria and Procedures for Classifying Over-the-Counter Drugs as Generally Recognized as Safe and Effective and Not Misbranded—Time and Extent Applications for Nonprescription Drug Products,Notice,60 Day Proposed Information Collection,2020-07-30T04:00:00Z,2020,7,2020-07-30T04:00:00Z,2020-09-29T03:59:59Z,2020-07-30T13:30:08Z,2020-16528,0,0,09000064847bd2f1